90 results
8-K
EX-99.1
ENZ
Enzo Biochem, Inc.
1 Feb 24
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
8:33am
their dedication and passionate commitment to the Company and their focus on creating shareholder value”, stated Steven Pully, Chairman of the Board of Enzo
DEFR14A
ENZ
Enzo Biochem, Inc.
21 Dec 23
Revised proxy
4:48pm
outreach to its top shareholders as part of its commitment to be responsive to shareholder concerns. During the past year, as in prior years, the Board … by contacting Investor Relations at (631) 755-5500.
Diversity Policy - As part of the Company’s commitment to improved governance and in connection
8-K
EX-99.1
ENZ
Enzo Biochem, Inc.
6 Sep 23
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
6:12pm
CEO.
“We thank Hamid for the commitment he has brought to Enzo Biochem, Inc.” Chairperson of the Board Mary Tagliaferri, MD stated, “Hamid
8-K
EX-99.1
83usrigfwah25c5h
24 Jul 23
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
4:32pm
424B3
sndjft
18 Jul 23
Prospectus supplement
9:42pm
424B3
stgtwh0lkl 4svu
21 Jun 23
Prospectus supplement
8:44pm
DEFM14A
24miw660
24 Apr 23
Proxy related to merger
4:01pm
PREM14A
7xf o4978vh4
12 Apr 23
Preliminary proxy related to merger
8:49pm
8-K
lgo15r39406q3g7mcei
5 Apr 23
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
lety7tjatwfautz5k
5 Apr 23
Entry into a Material Definitive Agreement
4:15pm
DEFR14A
gw359mf1l866
20 Dec 22
Revised proxy
9:49pm